S Cantara

Summary

Affiliation: University of Siena
Country: Italy

Publications

  1. ncbi Lack of mutations of the telomerase RNA component in familial papillary thyroid cancer with short telomeres
    Silvia Cantara
    Section of Endocrinology and Metabolism, Department of Internal Medicine, Endocrinology and Metabolism, and Biochemistry, University of Siena, Siena, Italy
    Thyroid 22:363-8. 2012
  2. ncbi Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer
    Silvia Cantara
    Section of Endocrinology and Metabolism, Department of Internal Medicine, Endocrinology and Metabolism and Biochemistry, University of Siena, Siena, Italy
    Thyroid Res 3:4. 2010
  3. ncbi TAT-BH4 counteracts Abeta toxicity on capillary endothelium
    S Cantara
    Department Molecular Biology, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
    FEBS Lett 581:702-6. 2007
  4. ncbi FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium
    S Donnini
    Department of Molecular Biology, University of Siena, Via A. Moro 2, 53100 Siena, Italy
    Cell Death Differ 13:1088-96. 2006
  5. ncbi Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress
    S Cantara
    Pharmacology Section, Department of Molecular Biology, University of Siena, Siena, Italy
    J Vasc Res 41:202-7. 2004
  6. ncbi Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity
    M Capezzone
    Section of Endocrinology and Metabolism, Department of Internal Medicine, Endocrinology and Metabolism and Biochemistry, University of Siena, Policlinico Santa Maria alle Scotte, Viale Bracci 1, 53100 Siena, Italy
    Endocr Relat Cancer 15:1075-81. 2008

Collaborators

  • M Ziche
  • F Pacini
  • M Capezzone
  • S Donnini
  • P Toti
  • L Brilli
  • G Caruso
  • G Busonero
  • A F Carli
  • S Marchisotta
  • A Pammolli
  • K Pazaitou-Panayiotou
  • S Capitani
  • A Giachetti
  • L Morbidelli

Detail Information

Publications6

  1. ncbi Lack of mutations of the telomerase RNA component in familial papillary thyroid cancer with short telomeres
    Silvia Cantara
    Section of Endocrinology and Metabolism, Department of Internal Medicine, Endocrinology and Metabolism, and Biochemistry, University of Siena, Siena, Italy
    Thyroid 22:363-8. 2012
    ..The objective of the present study was to verify whether short telomeres observed in FPTC patients were related to mutations in TERC or shelterin genes...
  2. ncbi Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer
    Silvia Cantara
    Section of Endocrinology and Metabolism, Department of Internal Medicine, Endocrinology and Metabolism and Biochemistry, University of Siena, Siena, Italy
    Thyroid Res 3:4. 2010
    ..We concluded that the A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) is not correlated with the familial form of PTC, even when the tumor was in the context of multinodular goiter...
  3. ncbi TAT-BH4 counteracts Abeta toxicity on capillary endothelium
    S Cantara
    Department Molecular Biology, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
    FEBS Lett 581:702-6. 2007
    ....
  4. ncbi FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium
    S Donnini
    Department of Molecular Biology, University of Siena, Via A. Moro 2, 53100 Siena, Italy
    Cell Death Differ 13:1088-96. 2006
    ..In conclusion, we demonstrate that FGF-2 protects EC from the effects of excess Abeta1-40, suggesting that it may attenuate the consequences of Abeta deposition in pathologies as CAA...
  5. ncbi Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress
    S Cantara
    Pharmacology Section, Department of Molecular Biology, University of Siena, Siena, Italy
    J Vasc Res 41:202-7. 2004
    ..TAT-BH4 reduced caspase-3 activity and prevented apoptotic cell death. CONCLUSION: Our results indicate that TAT-BH4 peptide can protect endothelial cells from ROS-induced apoptosis...
  6. ncbi Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity
    M Capezzone
    Section of Endocrinology and Metabolism, Department of Internal Medicine, Endocrinology and Metabolism and Biochemistry, University of Siena, Policlinico Santa Maria alle Scotte, Viale Bracci 1, 53100 Siena, Italy
    Endocr Relat Cancer 15:1075-81. 2008
    ..04) when compared with the first generation. In conclusion, FNMTC displays the features of clinical 'anticipation' with the second generation acquiring the disease at an earlier age and having more advanced disease at presentation...